• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在表达AML1-ETO的髓系白血病母细胞中p21/WAF/Cip1的转录上调。

Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.

作者信息

Berg Tobias, Fliegauf Manfred, Burger Jan, Staege Martin S, Liu Shaohua, Martinez Natalia, Heidenreich Olaf, Burdach Stefan, Haferlach Torsten, Werner Milton H, Lübbert Michael

机构信息

Department of Medicine, Division Hematology/Oncology, University of Freiburg Medical Center, Hugstetter Str. 55, D-79106 Freiburg, Germany.

出版信息

Haematologica. 2008 Nov;93(11):1728-33. doi: 10.3324/haematol.13044. Epub 2008 Sep 11.

DOI:10.3324/haematol.13044
PMID:18790797
Abstract

An inducible model for conditional expression of AML1-ETO in myeloid U-937 cells was generated previously to determine cellular effects of AML1-ETO and to identify target genes. Induction of AML1-ETO expression in U-937 resulted in reduced cell growth, G1 arrest and apoptosis. Microarray analysis showed more genes up-regulated than down-regulated (180 vs. 69). Clustering of AML1-ETO-positive and -negative cell lines was possible based on these differentially expressed genes. p21/WAF/Cip1 (CDKN1A) was up-regulated 4.6-fold upon induction of AML1-ETO which was confirmed in additional experiments. Knock-down of AML1-ETO by siRNA could reduce p21/WAF/Cip1 expression in Kasumi-1 cells. mRNA expression analysis of p21/WAF/Cip1 in a large cohort of acute myeloid leukemia patients demonstrated a significantly higher expression in AML1-ETO-positive leukemia. The increased expression of p21/WAF/Cip1 in primary leukemic blasts suggests that elevated p21/WAF/Cip1 levels may contribute to specific features observed in AML1-ETO positive leukemia.

摘要

先前构建了一种可诱导模型,用于在髓系U-937细胞中条件性表达AML1-ETO,以确定AML1-ETO的细胞效应并鉴定靶基因。在U-937细胞中诱导AML1-ETO表达导致细胞生长减少、G1期阻滞和凋亡。微阵列分析显示上调的基因比下调的基因更多(180个对69个)。基于这些差异表达基因,可对AML1-ETO阳性和阴性细胞系进行聚类。诱导AML1-ETO后,p21/WAF/Cip1(CDKN1A)上调了4.6倍,这在其他实验中得到了证实。用小干扰RNA敲低AML1-ETO可降低Kasumi-1细胞中p21/WAF/Cip1的表达。对一大群急性髓系白血病患者的p21/WAF/Cip1进行mRNA表达分析显示,在AML1-ETO阳性白血病中其表达显著更高。原发性白血病母细胞中p21/WAF/Cip1表达增加表明,p21/WAF/Cip1水平升高可能导致AML1-ETO阳性白血病中观察到的特定特征。

相似文献

1
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.在表达AML1-ETO的髓系白血病母细胞中p21/WAF/Cip1的转录上调。
Haematologica. 2008 Nov;93(11):1728-33. doi: 10.3324/haematol.13044. Epub 2008 Sep 11.
2
Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.木犀草素A是一种天然抗癌黄酮类化合物,可诱导t(8;21)阳性的Kasumi-1细胞和原发性急性髓性白血病细胞分化。
J Cancer Res Clin Oncol. 2016 Jul;142(7):1449-59. doi: 10.1007/s00432-016-2160-1. Epub 2016 Apr 16.
3
AML1-ETO and CCND2 overexpression cooperate to drive acute myeloid leukemia initiation and progression.AML1-ETO与CCND2的过表达协同作用,驱动急性髓系白血病的起始和进展。
J Leukoc Biol. 2025 Jun 4;117(6). doi: 10.1093/jleuko/qiaf072. Epub 2025 May 22.
4
ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.ETO和AML1磷酸化蛋白在CD34+造血祖细胞中表达:对t(8;21)白血病发生及残留疾病监测的意义。
Blood. 1996 Sep 1;88(5):1813-23.
5
Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.条件性AML1-ETO癌基因的表达绕过胚胎致死性,建立了人类t(8;21)急性髓系白血病的小鼠模型。
Cancer Cell. 2002 Feb;1(1):63-74. doi: 10.1016/s1535-6108(02)00016-8.
6
The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.在t(8;21)髓系白血病中,髓系主要调节转录因子PU.1被AML1-ETO失活。
Blood. 2003 Jan 1;101(1):270-7. doi: 10.1182/blood-2002-04-1288. Epub 2002 Aug 29.
7
Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia. runt 相关转录因子 1 对急性髓系白血病血管内皮生长因子表达的抑制作用。
Cancer Res. 2011 Apr 1;71(7):2761-71. doi: 10.1158/0008-5472.CAN-10-0402. Epub 2011 Mar 29.
8
Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO.威廉姆斯-贝伦综合征关键区域5/非T细胞激活连接蛋白:一种AML1/ETO的新型靶基因。
Oncogene. 2004 Dec 2;23(56):9070-81. doi: 10.1038/sj.onc.1208042.
9
The AML1/ETO fusion protein activates transcription of BCL-2.AML1/ETO融合蛋白激活BCL-2的转录。
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14059-64. doi: 10.1073/pnas.93.24.14059.
10
Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.特定蛋白重定向作为t(8;21)白血病的一种转录治疗方法。
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8448-53. doi: 10.1073/pnas.1330293100. Epub 2003 Jun 20.

引用本文的文献

1
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon.靶向急性白血病的增殖信号和细胞周期机制:新分子即将出现。
Molecules. 2023 Jan 26;28(3):1224. doi: 10.3390/molecules28031224.
2
Cyclin-dependent kinase inhibitors in malignant hematopoiesis.恶性造血中的细胞周期蛋白依赖性激酶抑制剂
Front Oncol. 2022 Aug 11;12:916682. doi: 10.3389/fonc.2022.916682. eCollection 2022.
3
RUNX1T1 function in cell fate.RUNX1T1 在细胞命运中的功能。
Stem Cell Res Ther. 2022 Jul 28;13(1):369. doi: 10.1186/s13287-022-03074-w.
4
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.AML1/ETO 及其作为通过表观遗传机制调节基因转录的功能。
Oncogene. 2021 Sep;40(38):5665-5676. doi: 10.1038/s41388-021-01952-w. Epub 2021 Jul 30.
5
Definition of a small core transcriptional circuit regulated by AML1-ETO.AML1-ETO 调控的小核心转录回路的定义。
Mol Cell. 2021 Feb 4;81(3):530-545.e5. doi: 10.1016/j.molcel.2020.12.005. Epub 2020 Dec 30.
6
The RUNX1/RUNX1T1 network: translating insights into therapeutic options.RUNX1/RUNX1T1 网络:将见解转化为治疗选择。
Exp Hematol. 2021 Feb;94:1-10. doi: 10.1016/j.exphem.2020.11.005. Epub 2020 Nov 17.
7
Immunostimulation by OX40 Ligand Transgenic Ewing Sarcoma Cells.OX40配体转基因尤因肉瘤细胞的免疫刺激作用。
Front Oncol. 2015 Oct 27;5:242. doi: 10.3389/fonc.2015.00242. eCollection 2015.
8
AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.AML1-ETO 驱动的急性白血病:发病机制和潜在治疗方法的深入了解。
Front Med. 2012 Sep;6(3):248-62. doi: 10.1007/s11684-012-0206-6. Epub 2012 Aug 9.
9
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.t(8;21)AML 细胞中 RUNX1/ETO 的耗竭导致染色质结构和转录因子结合的全基因组变化。
Leukemia. 2012 Aug;26(8):1829-41. doi: 10.1038/leu.2012.49. Epub 2012 Feb 20.
10
Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects.核心结合因子白血病的分子发病机制:现有知识和未来展望。
Int J Hematol. 2011 Aug;94(2):126-133. doi: 10.1007/s12185-011-0858-z. Epub 2011 May 3.